Can a snoezelen room calm young cancer patients?

NCT ID NCT07202507

Recruiting now Symptom relief Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether Snoezelen, a multisensory relaxation approach using lights, sounds, and textures, can reduce anxiety in children aged 8 to 17 who are hospitalized for chemotherapy. Twenty participants will compare their symptoms during a chemo cycle with Snoezelen sessions to a previous cycle without it. Researchers will use questionnaires and interviews to measure changes in anxiety, mood, and nausea.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Snoezelen multisensory relaxation sessions
What this could lead to: If it works, this could offer a drug-free way to ease anxiety and improve well-being for children undergoing chemotherapy.
What could go wrong: This is a very small early-stage study with only 20 participants, so results may not apply broadly. The effect on anxiety is measured subjectively, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHIMIOTHÉRAPIE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHIMIOTHÉRAPIE PEDIATRIC CANCER SNOEZELEN SYMPTOMATOLOGIE ANXIEUSE

Contacts and locations

Locations

Centre Oscar Lambret
RECRUITING

Lille, 59000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.